Synthesis and biological evaluation of some 4-aminoquinoline derivatives as potential antitubercular agents

被引:13
作者
Alegaon, Shankar [1 ]
Kashniyal, Kamlesh [1 ]
Kuncolienkar, Sanket [1 ]
Kavalapure, Rohini [1 ]
Salve, Preeti [1 ]
Palled, Mahesh [1 ]
Suryawanshi, Shailendra [1 ]
Jalalpure, Sulin [2 ,3 ]
机构
[1] KLE Acad Higher Educ & Res, Dept Pharmaceut Chem, KLE Coll Pharm, Belagavi 590010, Karnataka, India
[2] KLE Acad Higher Educ & Res, KLE Coll Pharm, Dept Pharmacognosy & Phytochem, Belagavi 590010, Karnataka, India
[3] KLE Acad Higher Educ & Res, Dr Prabhakar Kore Basic Sci Res Ctr, Belagavi 590010, Karnataka, India
关键词
Thiosemicarbazones; Semicarbazones; Quinoline; Antitubercular; Cytotoxicity; INHIBITORS; TUBERCULOSIS; DISCOVERY; CHALCONES; DESIGN;
D O I
10.1186/s43094-019-0016-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background Based on bioisosteric similarities with thiacetazone, a series of 7-chloro-4-aminoquinoline derivatives have been designed and synthesized. The target compounds were elucidated by NMR, mass, and FTIR spectral data. All synthesized compounds were evaluated for their in vitro antitubercular activity against Mycobacterium tuberculosis H(37)Rv (MTB), and human dermal fibroblast cell lines were used to assess toxicity of selected ligands. Results All of the designed compounds showed inhibition of MTB with MIC of 1.56-50 mu M. Among the tested compounds, 7c and 7g proved to be most potent MTB inhibitors (MIC = 1.56 mu M). Conclusions The outcome of present study suggests that most of the synthesized compounds are sensitive to Mycobacterium tuberculosis and showed acceptable range for molecular parameters. Thus, 7-chloro-4-aminoquinolines could be a useful lead for the development of new MTB inhibitory agents.
引用
收藏
页数:12
相关论文
共 25 条
[21]   Thiosemicarbazones, semicarbazones, dithiocarbazates and hydrazide/hydrazones: Anti-Mycobacterium tuberculosis activity and cytotoxicity [J].
Pavan, Fernando R. ;
Maia, Pedro I. da S. ;
Leite, Sergio R. A. ;
Deflon, Victor M. ;
Batista, Alzir A. ;
Sato, Daisy N. ;
Franzblau, Scott G. ;
Leite, Clarice Q. F. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (05) :1898-1905
[22]   Substituted quinolinyl chalcones and quinolinyl pyrimidines as a new class of anti-infective agents [J].
Sharma, Moni ;
Chaturvedi, Vinita ;
Manju, Y. K. ;
Bhatnagar, Shalini ;
Srivastava, Kumkum ;
Puri, S. K. ;
Chauhan, Prem M. S. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2009, 44 (05) :2081-2091
[23]   New drugs and perspectives for new anti-tuberculosis regimens [J].
Tiberi, S. ;
Munoz-Torrico, M. ;
Duarte, R. ;
Dalcolmo, M. ;
D'Ambrosio, L. ;
Migliori, G. -B. .
PULMONOLOGY, 2018, 24 (02) :86-98
[24]  
World Health Organization, 2018, GLOB TUB REP 2018 GL
[25]   Synthesis and biological evaluation of new 4-carboxyl quinoline derivatives as cyclooxygenase-2 inhibitors [J].
Zarghi, Afshin ;
Ghodsi, Razieh ;
Azizi, Ebrahim ;
Daraie, Bahram ;
Hedayati, Mehdi ;
Dadrass, Orkideh G. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (14) :5312-5317